Skip to main content
Top
Published in: Archives of Virology 2/2016

01-02-2016 | Original Article

The c-Jun N-terminal kinase (JNK) is involved in H5N1 influenza A virus RNA and protein synthesis

Authors: Shouping Zhang, Haiyan Tian, Jingmin Cui, Jin Xiao, Ming Wang, Yanxin Hu

Published in: Archives of Virology | Issue 2/2016

Login to get access

Abstract

The activation of c-jun N-terminal kinases (JNK) was previously shown to be required for efficient influenza A virus replication, although a detailed mechanism has not been reported. In this study, we found that replication of H5N1 influenza virus was influenced by the JNK inhibitor SP600125. The results of time course experiments suggested that SP600125 inhibited an early post-entry step of viral infection but did not affect nucleocytoplasmic trafficking of the viral ribonucleoprotein complex. The levels of influenza virus genomic RNA (vRNA), but not the corresponding cRNA or mRNA, were specifically reduced by SP600125 in virus-infected cells, indicating that the JNK protein is intimately involved in vRNA synthesis. Additionally, SP600125 affected H5N1 virus protein synthesis, because NS1, PB1, PB2, HA and M1 protein production was impaired. Thus, our data demonstrated a critical role of the JNK protein in the regulation of vRNA and protein synthesis during virus infection. This enhances our understanding of the complicated signal transduction network involved in influenza A virus replication.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bogoyevitch MA, Arthur PG (2008) Inhibitors of c-Jun N-terminal kinases: JuNK no more? Biochim Biophys Acta 1784:76–93CrossRefPubMed Bogoyevitch MA, Arthur PG (2008) Inhibitors of c-Jun N-terminal kinases: JuNK no more? Biochim Biophys Acta 1784:76–93CrossRefPubMed
2.
go back to reference Droebner K, Pleschka S, Ludwig S, Planz O (2011) Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo. Antivir Res 92:195–203CrossRefPubMed Droebner K, Pleschka S, Ludwig S, Planz O (2011) Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo. Antivir Res 92:195–203CrossRefPubMed
3.
go back to reference Ehrhardt C, Marjuki H, Wolff T, Nurnberg B, Planz O, Pleschka S, Ludwig S (2006) Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell Microbiol 8:1336–1348CrossRefPubMed Ehrhardt C, Marjuki H, Wolff T, Nurnberg B, Planz O, Pleschka S, Ludwig S (2006) Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell Microbiol 8:1336–1348CrossRefPubMed
4.
go back to reference Ehrhardt C, Seyer R, Hrincius ER, Eierhoff T, Wolff T, Ludwig S (2010) Interplay between influenza A virus and the innate immune signaling. Microbes Infect 12:81–87CrossRefPubMed Ehrhardt C, Seyer R, Hrincius ER, Eierhoff T, Wolff T, Ludwig S (2010) Interplay between influenza A virus and the innate immune signaling. Microbes Infect 12:81–87CrossRefPubMed
5.
go back to reference Gaur P, Munjal A, Lal SK (2011) Influenza virus and cell signaling pathways. Med Sci Monit 17:148–154CrossRef Gaur P, Munjal A, Lal SK (2011) Influenza virus and cell signaling pathways. Med Sci Monit 17:148–154CrossRef
6.
go back to reference Haasbach E, Pauli EK, Spranger R, Mitzner D, Schubert U, Kircheis R, Planz O (2011) Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses. Antivir Res 91:304–313CrossRefPubMed Haasbach E, Pauli EK, Spranger R, Mitzner D, Schubert U, Kircheis R, Planz O (2011) Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses. Antivir Res 91:304–313CrossRefPubMed
7.
go back to reference Hale B, Randall R, Ortin J, Jackson D (2008) The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89:2359–2376CrossRefPubMed Hale B, Randall R, Ortin J, Jackson D (2008) The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89:2359–2376CrossRefPubMed
8.
go back to reference Stephenson I, ZamBon M (2002) The epidemiology of influenza. Occup Med 52:241–247CrossRef Stephenson I, ZamBon M (2002) The epidemiology of influenza. Occup Med 52:241–247CrossRef
9.
10.
go back to reference Kumar N, Liang Y, Parslow TG, Liang Y (2011) Receptor tyrosine kinase inhibitors block multiple steps of influenza a virus replication. J Virol 85:2818–2827PubMedCentralCrossRefPubMed Kumar N, Liang Y, Parslow TG, Liang Y (2011) Receptor tyrosine kinase inhibitors block multiple steps of influenza a virus replication. J Virol 85:2818–2827PubMedCentralCrossRefPubMed
11.
go back to reference Leppä SBD (1999) Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene 18:6158–6162CrossRefPubMed Leppä SBD (1999) Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene 18:6158–6162CrossRefPubMed
12.
13.
go back to reference Ludwig S, Ehrhardt C, Neumeier ER, Kracht M, Rapp UR, Pleschka S (2001) Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. J Biol Chem 276:10990–10998CrossRef Ludwig S, Ehrhardt C, Neumeier ER, Kracht M, Rapp UR, Pleschka S (2001) Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. J Biol Chem 276:10990–10998CrossRef
14.
go back to reference Ludwig S, Planz O, Pleschka S, Wolff T (2003) Influenza-virus-induced signaling cascades targets for antiviral therapy. Trends Mol Med 9:46–52CrossRefPubMed Ludwig S, Planz O, Pleschka S, Wolff T (2003) Influenza-virus-induced signaling cascades targets for antiviral therapy. Trends Mol Med 9:46–52CrossRefPubMed
16.
go back to reference Nacken W, Ehrhardt C, Ludwig S (2012) Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses. Biol Chem 393:525–534CrossRefPubMed Nacken W, Ehrhardt C, Ludwig S (2012) Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses. Biol Chem 393:525–534CrossRefPubMed
18.
go back to reference Song JM, Lee KH, Seong BL (2005) Antiviral effect of catechins in green tea on influenza virus. Antivir Res 68:66–74CrossRefPubMed Song JM, Lee KH, Seong BL (2005) Antiviral effect of catechins in green tea on influenza virus. Antivir Res 68:66–74CrossRefPubMed
19.
go back to reference Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ (2003) Requirement of JNK for stress- induced activation of the cytochrome c-mediated death pathway. Science 288:870–874CrossRef Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ (2003) Requirement of JNK for stress- induced activation of the cytochrome c-mediated death pathway. Science 288:870–874CrossRef
20.
go back to reference Xie J, Zhang S, Hu Y, Li D, Cui J, Xue J, Zhang G, Khachigian LM, Wong J, Sun L, Wang M (2014) Regulatory roles of c-jun in H5N1 influenza virus replication and host inflammation. Biochim Biophys acTa 1842:2479–2488CrossRefPubMed Xie J, Zhang S, Hu Y, Li D, Cui J, Xue J, Zhang G, Khachigian LM, Wong J, Sun L, Wang M (2014) Regulatory roles of c-jun in H5N1 influenza virus replication and host inflammation. Biochim Biophys acTa 1842:2479–2488CrossRefPubMed
21.
go back to reference Zhang H, Niu X, Qian Z, Qian J, Xuan B (2015) The c-Jun N-terminal kinase inhibitor SP600125 inhibits human cytomegalovirus replication. J Med Virol 9999:1–10 Zhang H, Niu X, Qian Z, Qian J, Xuan B (2015) The c-Jun N-terminal kinase inhibitor SP600125 inhibits human cytomegalovirus replication. J Med Virol 9999:1–10
Metadata
Title
The c-Jun N-terminal kinase (JNK) is involved in H5N1 influenza A virus RNA and protein synthesis
Authors
Shouping Zhang
Haiyan Tian
Jingmin Cui
Jin Xiao
Ming Wang
Yanxin Hu
Publication date
01-02-2016
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 2/2016
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-015-2668-8

Other articles of this Issue 2/2016

Archives of Virology 2/2016 Go to the issue